CIK 0001756262 · Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- Phone
- 9785520900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −80 | $163.09 | $13K | 20,975 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −32 | $164.68 | $5K | 20,943 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Sale 10b5-1 | −100 | $165.87 | $17K | 20,843 |
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,459 | 8,750 | ||
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −417 | 12,515 | ||
| 2024-09-03 | Khayal Tamer I Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,084 | 19,500 | ||
| 2024-08-27 | Corcoran Nicholas See Remarks | Option exercise | +7,810 | $66.10 | $516K | 28,915 |
| 2024-08-27 | Corcoran Nicholas See Remarks | Option exercise | +2,190 | $83.14 | $182K | 31,105 |
| 2024-08-27 | Corcoran Nicholas See Remarks | Sale | −10,000 | $176.02 | $1.8M | 21,105 |
| 2024-08-27 | Corcoran Nicholas See Remarks | Option exercise · Stock Option (Right to Buy) | −7,810 | 11,922 | ||
| 2024-08-27 | Corcoran Nicholas See Remarks | Option exercise · Stock Option (Right to Buy) | −2,190 | 15,442 | ||
| 2024-08-22 | Hassanein Waleed H President & CEO | Option exercise | +25,000 | $16.14 | $404K | 86,643 |
| 2024-08-22 | Hassanein Waleed H President & CEO | Sale | −25,000 | $175.00 | $4.4M | 61,643 |
| 2024-08-22 | Hassanein Waleed H President & CEO | Option exercise · Stock Option (Right to Buy) | −25,000 | 153,000 | ||
| 2024-08-21 | Hassanein Waleed H President & CEO | Option exercise | +20,000 | $16.00 | $320K | 81,643 |
| 2024-08-21 | Hassanein Waleed H President & CEO | Sale | −20,000 | $171.03 | $3.4M | 61,643 |
| 2024-08-21 | Hassanein Waleed H President & CEO | Option exercise · Stock Option (Right to Buy) | −20,000 | 265,714 | ||
| 2024-08-15 | Hassanein Waleed H President & CEO | Option exercise 10b5-1 | +8,625 | $13.28 | $115K | 70,268 |
| 2024-08-15 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −300 | $165.26 | $50K | 69,968 |
| 2024-08-15 | Hassanein Waleed H President & CEO | Sale 10b5-1 | −700 | $167.24 | $117K | 69,268 |
Page 8 of 20 · 390 trades